Analysis of Low Content Drug Tablets by Transmission Near Infrared Spectroscopy: Selection of Calibration Ranges According to Multivariate Detection and Quantitation Limits of PLS Models

被引:46
作者
Alcala, Manel [1 ]
Leon, Joshua [1 ]
Ropero, Jorge [1 ]
Blanco, Marcelo [2 ]
Romanach, Rodolfo J. [1 ]
机构
[1] Univ Puerto Rico, Fac Arts & Sci, Dept Chem, Analyt & Pharmaceut Lab, Mayaguez, PR 00681 USA
[2] Univ Autonoma Barcelona, Fac Sci, Analyt Chem Unit, Dept Chem, Bellaterra 08193, Spain
基金
美国国家科学基金会;
关键词
analytical chemistry; near-infrared spectroscopy; multivariate analysis; partial least squares; principal component analysis;
D O I
10.1002/jps.21373
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The content uniformity of low dose products is a major concern in the development of pharmaceutical formulations. Near infrared spectroscopy may be used to support the design and optimization of potent drug manufacturing processes through the analysis of blends and tablets in a relatively short time. A strategy for the selection of concentration ranges in the development of multivariate calibration is presented, evaluating the detection and quantitation limits of the obtained multivariate models. The strategy has been applied to the determination of an active principle in pharmaceutical tablets of low concentration (0-5%, w/w), using Fourier Transform Near Infrared (FT-NIR) transmission spectroscopy. The quantitation and detection limits decreased as the upper concentration level of the calibration models was reduced. The results obtained show that the selection of concentration ranges is a critical aspect during model design. The selection of wide concentration ranges with high levels is not recommended for the determination of analytes at minor levels (< 1%, w/w), even when the concentration of interest is within the range of the model. (c) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:5318-5327, 2008
引用
收藏
页码:5318 / 5327
页数:10
相关论文
共 16 条
[1]   STANDARD NORMAL VARIATE TRANSFORMATION AND DE-TRENDING OF NEAR-INFRARED DIFFUSE REFLECTANCE SPECTRA [J].
BARNES, RJ ;
DHANOA, MS ;
LISTER, SJ .
APPLIED SPECTROSCOPY, 1989, 43 (05) :772-777
[2]   Preparing calibration sets for use in pharmaceutical analysis by NIR spectroscopy [J].
Blanco, M. ;
Bautista, M. ;
Alcala, M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (03) :1236-1245
[3]   Determination of low analyte concentrations by near-infrared spectroscopy: Effect of spectral pretreatments and estimation of multivariate detection limits [J].
Blanco, Marcel ;
Castillo, Miguel ;
Peinado, Antonio ;
Beneyto, Rafael .
ANALYTICA CHIMICA ACTA, 2007, 581 (02) :318-323
[4]   A process analytical technology approach based on near infrared spectroscopy:: Tablet hardness, content uniformity, and dissolution test measurements of intact tablets [J].
Blanco, Marcelo ;
Alcala, Manel ;
Gonzalez, Josep M. ;
Torrasz, Ester .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (10) :2137-2144
[5]  
Blanco M, 2005, PROCESS ANALYTICAL TECHNOLOGY: SPECTROSCOPIC TOOLS AND IMPLEMENTATION STRATEGIES FOR THE CHEMICAL AND PHARMACEUTICAL INDUSTRIES, P362, DOI 10.1002/9780470988459.ch10
[6]   Application of transmission near-infrared spectroscopy to uniformity of content testing of intact steroid tablets [J].
Broad, NW ;
Jee, RD ;
Moffat, AC ;
Smith, MR .
ANALYST, 2001, 126 (12) :2207-2211
[7]   Near-infrared determination of active substance content in intact low-dosage tablets [J].
Chalus, P ;
Roggo, Y ;
Walter, S ;
Ulmschneider, M .
TALANTA, 2005, 66 (05) :1294-1302
[8]   DETECTION LIMITS WITH SPECIFIED ASSURANCE PROBABILITIES [J].
CLAYTON, CA ;
HINES, JW ;
ELKINS, PD .
ANALYTICAL CHEMISTRY, 1987, 59 (20) :2506-2514
[9]   Standard error of prediction for multiway PLS 1. Background and a simulation study [J].
Faber, NM ;
Bro, R .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2002, 61 (1-2) :133-149
[10]   Validation of a near-infrared transmission spectroscopic procedure, part A: validation protocols [J].
Mark, H ;
Ritchie, GE ;
Roller, RW ;
Ciurczak, EW ;
Tso, C ;
MacDonald, SA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (02) :251-260